Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

• Status: Completed
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial is conducted in Europe. The aim of this observational study is to evaluate the blood glucose control (HbA1c) using NovoRapid® (insulin aspart) and Levemir® (insulin detemir) after switch from human insulins for treatment of type 1 diabetes under normal clinical practice conditions in Romania.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Insulin; Insulin Aspart; Insulin Detemir; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Any subject with type 1 diabetes who is treated with human rapid and intermediate (NPH) insulin in basal-bolus regimen

Exclusion Criteria:

• Subjects currently being treated with insulin aspart and insulin detemir

• Subjects who were previously enrolled in this study

• Subjects with a hypersensitivity to insulin aspart or to any of the excipients

• Subjects with a hypersensitivity to insulin detemir or to any of the excipients

• Women who are pregnant or have the intention of becoming pregnant within next 6 months